Lusine Harutyunyan, Hematologist, R1 Researcher at Yeolyan Hematology and Oncology Center, and Adjunct Researcher at Immune Oncology Research Institute, shared a post on LinkedIn:
“Good News
I was lucky to contribute to a manuscript writing process under the leadership of Priv.-Doz. Mag. Dr. Elisabeth Zeilinger, a health psychologist and an exceptional leader in her field. Her work on anxiety and depression assessment in cancer patients, including those with hematologic malignancies, first caught my interest when I came across her publications.
During the last 5 months, this collaboration on COVID-19 vaccine effectiveness and antibody response in geriatric long-term care gave me a deeper understanding of the local research process and allowed me to contribute from a hematology perspective to topics related to aging, including immunosenescence and inflammaging. It was an exceptional experience to see how my hematology background could be applied from this perspective.
And now, just a bit more waiting to see it finally published․”
Other articles featuring Lusine Harutyunyan on OncoDaily.